Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Cixutumumab
Trade Name
Synonyms IMC-A12
Drug Descriptions

Cixutumumab (IMC-A12) is an antibody against membrane-bound IGF-1R that prevents IGF-1 binding, inhibiting PI3K/AKT pathway activation and potentially leading to decreased tumor cell proliferation and increased tumor cell death (PMID: 29520435, PMID: 29909907).

DrugClasses IGF1R Antibody 8
CAS Registry Number 947687-12-9
NCIT ID C79828


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Carboplatin + Cixutumumab + Paclitaxel Bevacizumab Carboplatin Cixutumumab Paclitaxel 0 0
Cetuximab + Cixutumumab Cetuximab Cixutumumab 0 0
Cixutumumab Cixutumumab 0 2
Cixutumumab + Everolimus + Octreotide acetate Cixutumumab Everolimus Octreotide acetate 0 0

Additional content available in CKB BOOST